PT  - JOURNAL ARTICLE
AU  - Bryan B. Hsu
AU  - Jeffrey C. Way
AU  - Pamela A. Silver
TI  - Stable neutralization of virulent bacteria using temperate phage in the mammalian gut
AID  - 10.1101/794222
DP  - 2019 Jan 01
TA  - bioRxiv
PG  - 794222
4099  - http://biorxiv.org/content/early/2019/10/07/794222.short
4100  - http://biorxiv.org/content/early/2019/10/07/794222.full
AB  - Elimination or alteration of select members of the gut microbiota is key to therapeutic efficacy. However, the complexity of these microbial inhabitants makes it challenging to precisely target bacteria without unexpected cascading effects. Here, we use bacteriophage to deliver exogenous genes to specific bacteria by genomic integration of temperate phage for long-lasting modification. As a real-world therapeutic test, we engineered λ phage to transcriptionally-repress shigatoxin by using genetic hybrids between λ and other lambdoid phages to overcome resistance encoded by the virulent prophage derived from enterohemorrhagic E. coli. We show that a single dose of engineered phage propagates throughout the bacterial community and reduces shigatoxin production in an enteric mouse model of infection without markedly affecting bacterial concentrations. We thus minimize the selection for resistance by relying on anti-virulence and not anti-bacterial action. Our work reveals a new framework for transferring functions to bacteria within their native environment.